Catherine Schulte
Stock Analyst at Baird
(4.26)
# 409
Out of 5,106 analysts
142
Total ratings
59.17%
Success rate
12.36%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $142 → $165 | $138.36 | +19.25% | 18 | Nov 25, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $72 → $88 | $101.59 | -13.38% | 15 | Nov 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $15 → $17 | $11.27 | +50.84% | 14 | Oct 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,414.60 | -13.05% | 10 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $579.94 | -2.23% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $230.83 | -0.79% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.29 | -39.21% | 6 | May 13, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $45.61 | -5.72% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $59.25 | +14.77% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $40.25 | -5.59% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $33.84 | -2.48% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $136.19 | +106.33% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $383.21 | -43.37% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $235.40 | -91.50% | 1 | Jun 28, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Outperform
Price Target: $142 → $165
Current: $138.36
Upside: +19.25%
Exact Sciences
Nov 4, 2025
Maintains: Outperform
Price Target: $72 → $88
Current: $101.59
Upside: -13.38%
Avantor
Oct 24, 2025
Maintains: Outperform
Price Target: $15 → $17
Current: $11.27
Upside: +50.84%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,414.60
Upside: -13.05%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $579.94
Upside: -2.23%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $230.83
Upside: -0.79%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.29
Upside: -39.21%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $45.61
Upside: -5.72%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $59.25
Upside: +14.77%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $40.25
Upside: -5.59%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $33.84
Upside: -2.48%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $136.19
Upside: +106.33%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $383.21
Upside: -43.37%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $235.40
Upside: -91.50%